Raymond James Financial’s Arcosa ACA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.4M Buy
98,950
+8,744
+10% +$1.09M ﹤0.01% 1821
2026
Q1
$9.47M Sell
90,206
-10,186
-10% -$1.16M ﹤0.01% 2072
2025
Q4
$10.7M Sell
100,392
-18,296
-15% -$1.85M ﹤0.01% 1911
2025
Q3
$11.1M Sell
118,688
-23,083
-16% -$2.15M ﹤0.01% 1835
2025
Q2
$12.3M Sell
141,771
-25,308
-15% -$2.12M ﹤0.01% 1720
2025
Q1
$12.9M Buy
167,079
+2,524
+2% +$232K ﹤0.01% 1626
2024
Q4
$15.9M Buy
+164,555
New +$16.5M 0.01% 1489

Other funds holding ACA

Raymond James Financial's ACA Position: Q2 2026 in Review

Raymond James Financial increased its Arcosa (ACA) stake by 9.7% in Q2 2026, buying an estimated $1.09M and bringing the position to 98,950 shares worth $14.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1821.

Raymond James Financial first reported a position in ACA in Q4 2024 and has held it in 7 quarters since. The position peaked at $15.9M in Q4 2024. 428 funds tracked by Wall St. Rank hold ACA as of Q2 2026.

  • Raymond James Financial held 98,950 shares of Arcosa worth $14.4M as of Q2 2026.
  • Raymond James Financial bought 8,744 Arcosa shares in Q2 2026, an estimated $1.09M.
  • Arcosa made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #1821 holding.
  • Raymond James Financial first reported a position in Arcosa in Q4 2024 and has held it in 7 quarters since.
  • Raymond James Financial's Arcosa position peaked at $15.9M in Q4 2024.
  • 428 funds tracked by Wall St. Rank held Arcosa as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.